P1629: DISCONTINUATION OF TREATMENT WITH THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTER CLINICAL EXPERIENCE

por Santano, Ana María Mena, González, Patricia Tejuca, Jaime, Francisco José López, López, Rubén Clavero, Montaño, Adrián, Bello, Ihosvany Fernández
Publicado 2023

P1626: A SINGLE-CENTER EXPERIENCE IN INCREASING FACTOR VIII LEVELS TO ACHIEVE ZERO BLEEDING IN PATIENTS WITH SEVERE HEMOPHILIA A.

por López, Rubén Clavero, Jaime, Francisco José López, Aranda, Eva María Calavia, Santano, Ana María Mena, Montaño, Adrián, Bello, Ihosvany Fernández
Publicado 2023

P1618: REAL-WORLD DATA ON EMICIZUMAB: CORRELATION BETWEEN DRUG PLASMA LEVELS, GLOBAL PROCOAGULANT STATUS AND SPONTANEOUS JOINT ANNUALIZED BLEEDING RATE

por Jaime, Francisco José López, Marco-Rico, Ana, Montaño, Adrián, López, Francisco Daniel Muñoz, Palomo-Bravo, Ángeles, Marco, Pascual, Bello, Ihosvany Fernández
Publicado 2023

P1656: PROGRESSIVE WORSENING OF PROTHROMBOTIC PROFILE IN PATIENTS WITH AGGRESSIVE LYMPHOMA ON CHEMOTHERAPY

por Jaime, Francisco José López, Palacio, Heidy Johana Campo, Hurst, Kate, de Haro, Manuel Espeso, Ruiz, Francisco Cabrera, Márquez, Alberto Doblas, Bello, Ihosvany Fernández, Montaño, Adrián
Publicado 2023